Using HPLC to analyze (S)-oxiracetam and four related substances in the bulk drug of (S)-oxiracetam
- 1 February 2020
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 180, 113072
Abstract
No abstract availableKeywords
Funding Information
- National Key R&D Program of China (2017YFA0205400)
- National Natural Science Foundation of China (31872755, 81872811)
- Central Fundamental Research Funds for the Central Universities (021414380447, 02141480608201)
This publication has 13 references indexed in Scilit:
- Development and Validation of a RP-HPLC Method for the Simultaneous Determination of Aceglutamide and Oxiracetam in an Injection FormulationJournal of Chromatographic Science, 2014
- Drug safety, drug quality, drug analysisJournal of Pharmaceutical and Biomedical Analysis, 2008
- Oxiracetam pre- but not post-treatment prevented social recognition deficits produced with trimethyltin in ratsBehavioural Brain Research, 2005
- Rapid quantitative analysis of oxiracetam in human plasma by liquid chromatography/electrospray tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2004
- HPLC Determination of Oxiracetam, Its Impurities, and Piracetam in Pharmaceutical FormulationsAnalytical Letters, 1994
- Determination of oxiracetam in human plasma by reversed-phase high-performance liquid chromatography with fluorimetric detectionJournal of Chromatography A, 1993
- Oxiracetam in dementia: a double-blind, placebo-controlled studyActa Neurologica Scandinavica, 1992
- Oxiracetam in the treatment of multi-infarct dementiaProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1989
- Determination of oxiracetam in plasma and urine by column-switching high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Determination of oxiracetam in human serum and urine by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1987